Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENALIDOMIDE vs LEUCOVORIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENALIDOMIDE vs LEUCOVORIN: Safety Overview

Metric LENALIDOMIDE LEUCOVORIN
Total FAERS Reports 349,955 24,977
Deaths Reported 35,942 3,932
Death Rate 10.3% 15.7%
Hospitalizations 86,495 10,039
Average Patient Age 69.9 yrs 58.5 yrs
% Female Patients 50.0% 43.5%
FDA Approval Date Aug 3, 2023 Approved Prior to Jan 1, 1982
Manufacturer Padagis US LLC Leading Pharma, LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued